Should oral bisphosphonates be standard of care in women with early breast cancer?

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.90, Iss.3, 2005-04, pp. : 315-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should bisphosphonates be utilized in the adjuvant setting for breast cancer?

By Lipton Allan

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 627-636

Springer Publishing Company

Access to resources Recommend Favorite

Hypothesis: is antibiotic use associated with breast cancer?

By Velicer Christine M.

Cancer Causes and Control, Vol. 14, Iss. 8, 2003-01 ,pp. : 739-747

Springer Publishing Company

Access to resources Recommend Favorite

Is there a role for ovarian function suppression in operable breast cancer?

By Sparano Joseph

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 311-313

Springer Publishing Company

Access to resources Recommend Favorite

Are we missing the mTOR target in breast cancer?

By Johnston Stephen

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 607-611

Springer Publishing Company

Access to resources Recommend Favorite

Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?

By Gerber Bernd

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 613-624

Springer Publishing Company

Access to resources Recommend Favorite